FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA

Go back to FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
Asianada, Inc. (NASDAQ: ASND) Delayed: 257.93 +7.76 (3.10%)
Previous Close $250.17    52 Week High $21.79 
Open $252.50    52 Week Low $11.92 
Day High $258.16    P/E N/A 
Day Low $248.31    EPS $-0.07 
Volume 655,805